Abstract:Abstract Acute kidney injury (AKI) is defined as a rapid decline in renal function and is characterized by excessive renal inflammation and programmed death of resident cells. AKI shows high morbidity and mortality, and severe or repeated AKI can transition to chronic kidney disease (CKD) or even end-stage renal disease (ESRD); however, very few effective and specific therapies are available, except for supportive treatment. Growth factors, such as epidermal growth factor (EGF), insulin-like growth factor (IGF), and transforming growth factor-β (TGF-β), are significantly altered in AKI models and have been suggested to play critical roles in the repair process of AKI because of their roles in cell regeneration and renal repair. In recent years, a series of studies have shown evidence that growth factors, receptors, and downstream effectors may be highly involved in the mechanism of AKI and may function in the early stage of AKI in response to stimuli by regulating inflammation and programmed cell death. Moreover, certain growth factors or correlated proteins act as biomarkers for AKI due to their sensitivity and specificity. Furthermore, growth factors originating from mesenchymal stem cells (MSCs) via paracrine signaling or extracellular vesicles recruit leukocytes or repair intrinsic cells and may participate in AKI repair or the AKI-CKD transition. In addition, growth factor-modified MSCs show superior therapeutic potential compared to that of unmodified controls. In this review, we summarized the current therapeutic and diagnostic strategies targeting growth factors to treat AKI in clinical trials. We also evaluated the possibilities of other growth factor-correlated molecules as therapeutic targets in the treatment of AKI and the AKI-CKD transition.

Cell Cycle Arrest:A Key Point of AKI-to-CKD Transition

Research Progress of Mechanism of Cell Cycle Arrest in Chronic Renal Disease after Acute Renal Injury

Acute Kidney Injury and Cell Cycle Regulation

Mitochondrial Dysfunction and the AKI-to-CKD Transition

Cell Cycle Dysregulation and Renal Fibrosis

Cellular Senescence, A Novel Therapeutic Target For Mesenchymal Stem Cells In Acute Kidney Injury

Cellular senescence in acute kidney injury: Target and opportunity

Mechanism and prevention of the transformation from AKI to CKD

Cellular senescence and acute kidney injury

Cell-Cycle Dysregulation in the Pathogenesis of Diabetic Kidney Disease: an Update

Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming

AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.

AKI: an increasingly recognized risk factor for CKD development and progression

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury

Current Understanding of the Administration of Mesenchymal Stem Cells in Acute Kidney Injury to Chronic Kidney Disease Transition: a Review with a Focus on Preclinical Models

Research progress in the mechanism of cell cycle arrest in sepsis-induced acute kidney injury

Role of endoplasmic reticulum stress and autophagy in the transition from acute kidney injury to chronic kidney disease

Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression

The Interaction Between Cellular Senescence and Chronic Kidney Disease As a Therapeutic Opportunity

Mitochondrial Signaling, the Mechanisms of AKI-to-CKD Transition and Potential Treatment Targets